Patients with atrial fibrillation usually require a stroke prevention therapy, depending on their individual risk for stroke. During consultation, we determine patients’ individual risk as a basis to establish individual strategies for stroke prevention.
As stroke resulting from atrial fibrillation usually arises due to clot formation in the left atrial tube (LAA), the interventional closure of the atrial appendage via a so-called atrial occlusion has been established as a therapeutic approach in recent years. This offers patients with a contraindication for long-term anticoagulation therapy, for example after heavy bleeding, an equivalent level of protection against thromboembolic stroke. In the Section for Heart Rhythm Management and Electrophysiology of the Department of Cardiology and Angiology, we routinely implant various occluder models. Since the anatomy of the atrial appendage can vary greatly, the individual anatomy of each patient is taken into account when considering the most suitable system for implantation.